Steven Haffner

Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.

R. Frye, G. Bakris, W. Hsueh, 2005, Metabolic syndrome and related disorders.

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study

S. Grundy, P. Barter, D. Waters, 2006, The Lancet.

Hyperglycemia as a cardiovascular risk factor.

S. Haffner, H. Cassells, Steven Haffner, 2003, The American journal of medicine.

The Mexico City Diabetes Study: a population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes.

S. Haffner, C. González, M. Stern, 2009, Nutrition reviews.

Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay

K. Polonsky, D. Porte, R. Chance, 1996, Diabetes.